pfizer scores patent victory over lipitor pfizer inc preserved its u s market exclusivity for the cholesterol lowering drug lipitor and agreed to pay nearly &# million to resolve government investigations of its promotion of another drug the supreme court declined to intervene in ranbaxy laboratories ltd s appeal of a lower court ruling upholding a pfizer patent for lipitor ranbaxy an indian generic drug maker wanted to sell a generic version of lipitor the high courts decision not to get involved appears to settle the matter in pfizers favor the new york drug company said it was "pleased" by the decision while a ranbaxy spokesman declined to comment pfizer said it agreed to pay &# million in a settlement with the justice department over pharmacias promotion of the drug genotropin before pfizer acquired pharmacia in genotropin is a human growth hormone 
